Morgan Stanley Maintains Overweight, $36 Target on Oracle

Loading...
Loading...
Morgan Stanley reiterates its Overweight rating and $36 target price on Oracle
ORCL
as the company sees a myriad of catalysts in CY12. Morgan Stanley says, “While we expect Q2 to be solid, our positive thesis on ORCL is about several CY12 drivers including a) a firm apps cycle converging with the Fusion Apps catalyst, b) an improving middleware & analytics story, c) hardware accelerating to 10%+ growth on Exa-family strength and d) margins expanding faster than people expect.” ORCL closed at $29.87 per share on Wednesday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...